Matches in Wikidata for { <http://www.wikidata.org/entity/Q97682239> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q97682239 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q97682239 description "scientific article published on 01 April 2020" @default.
- Q97682239 description "wetenschappelijk artikel" @default.
- Q97682239 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q97682239 name "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 name "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 type Item @default.
- Q97682239 label "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 label "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 prefLabel "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 prefLabel "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 P1476 Q97682239-E63C016C-583B-43A6-8047-94BDCBEF79C2 @default.
- Q97682239 P2093 Q97682239-37F72651-225A-4B35-81C2-885AAB10C1ED @default.
- Q97682239 P2093 Q97682239-8CBC0150-31C3-43BE-8613-98287A509374 @default.
- Q97682239 P2093 Q97682239-8E5E02DE-E28A-4C24-8FED-A354839EECBF @default.
- Q97682239 P2093 Q97682239-B1ED86AC-0F93-40E7-9BB2-2CC9F768E8BC @default.
- Q97682239 P2093 Q97682239-C1131E26-EC1C-4A40-B343-4B128BCC3315 @default.
- Q97682239 P275 Q97682239-2830b167-d046-4ae1-ac74-0b0710a0a108 @default.
- Q97682239 P304 Q97682239-C1161BD4-A4E9-47ED-88B7-ED8DCB05D681 @default.
- Q97682239 P31 Q97682239-3314A437-AC3B-42A0-B08A-7A2B222BFAA3 @default.
- Q97682239 P356 Q97682239-DC180CC6-233C-45DF-B627-4788EBA1436F @default.
- Q97682239 P433 Q97682239-A23368E0-B8F8-46A1-A901-8A21E764FAA2 @default.
- Q97682239 P478 Q97682239-95AACB3D-00C1-43AC-AA24-5C6C7229D71B @default.
- Q97682239 P577 Q97682239-683E8EA0-B848-4147-A1DE-0569BA406E58 @default.
- Q97682239 P6216 Q97682239-a398c727-433e-44b1-bed5-dc20b04aab10 @default.
- Q97682239 P698 Q97682239-C30B220B-F858-46A8-B036-C69EF7139788 @default.
- Q97682239 P921 Q97682239-479EFACA-5A66-4020-AFBB-CAC039AF1653 @default.
- Q97682239 P932 Q97682239-C51AF4CC-0BD9-4C5C-A3A4-13CB693FA1DF @default.
- Q97682239 P356 S-0040-1710032 @default.
- Q97682239 P698 32704613 @default.
- Q97682239 P1476 "Synergistic Effect of Bypassing Agents and Sequence Identical Analogue of Emicizumab and Fibrin Clot Structure in the In Vitro Model of Hemophilia A" @default.
- Q97682239 P2093 "Aleksandra Antovic" @default.
- Q97682239 P2093 "Iva Pruner" @default.
- Q97682239 P2093 "Jovan Antovic" @default.
- Q97682239 P2093 "Nida Mahmoud Hourani Soutari" @default.
- Q97682239 P2093 "Yanan Zong" @default.
- Q97682239 P275 Q20007257 @default.
- Q97682239 P304 "e94-e103" @default.
- Q97682239 P31 Q13442814 @default.
- Q97682239 P356 "10.1055/S-0040-1710032" @default.
- Q97682239 P433 "2" @default.
- Q97682239 P478 "4" @default.
- Q97682239 P577 "2020-04-01T00:00:00Z" @default.
- Q97682239 P6216 Q50423863 @default.
- Q97682239 P698 "32704613" @default.
- Q97682239 P921 Q2092064 @default.
- Q97682239 P932 "7373667" @default.